Name | 2-Methyl-3-[(2S)-2-pyrrolidinylmethoxy]pyridine |
---|
Description | Pozanicline (ABT-089) selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes, is a novel cholinergic agent that is a partial agonist at α4β2* nAChRs (Ki=16 nM) and shows high selectivity for α6β2* and α4α5β2 nAChR subtypes, the binding affinity (Ki, rat) for Pozanicline to [3H] cytisine sites is 16.7 nM.Pozanicline reverses nicotine withdrawal-induced cognitive deficits, may be an effective component of novel therapeutic strategies for nicotine addiction[1]. |
---|---|
Related Catalog | |
Target |
Ki: 16 nM (α4β2* nAChR)[1] |
References |
Density | 1.046g/cm3 |
---|---|
Boiling Point | 302.7ºC at 760mmHg |
Molecular Formula | C11H16N2O |
Molecular Weight | 192.25800 |
Flash Point | 136.9ºC |
Exact Mass | 192.12600 |
PSA | 34.15000 |
LogP | 1.84960 |
Vapour Pressure | 0.000975mmHg at 25°C |
Index of Refraction | 1.517 |